§ Federal grant opportunity · PAR-27-090
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)
National Institutes of Health is accepting applications for Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional). The deadline is November 5, 2029 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- November 5, 2029
- Award range
- Award amount not published
- Eligibility
- nonprofits non higher education with 501c3, private institutions of higher education, city or township governments, special district governments, for profit organizations other than small businesses, state governments, other, public and state institutions of higher education, nonprofits non higher education without 501c3, public and indian housing authorities, other native american tribal organizations, federally recognized native american tribal governments, independent school districts, county governments, small businesses
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-27-090
Program overview
The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications proposing research on palliative care across the lifespan for persons with serious illnesses and/or their care partners relevant to the missions of participating NIH Institutes, Centers, and Offices (ICOs), including projects focused on palliative care access, use, and quality. Applications may propose hypothesis-driven, milestone-defined palliative care traditional efficacy (Stage II), real-world efficacy (Stage III), effectiveness (Stage IV), and/or dissemination and implementation (Stage V) clinical trials in alignment with the NIH Stage Model (Stages II-V) and relevant Institute or Center policies. Applications may propose non-clinical trial palliative care research, such as health services research, methodologic research, natural experiments, or observational studies. Recipients will become members of the research community facilitated by the NIH-funded Advancing the Science of Palliative Care Across the Lifespan (ASCENT) Consortium. NOTE : This NOFO is not appropriate for applications proposing new intervention generation, refinement, modification, adaptation, and/or pilot testing (Stage I of the NIH Stage Model) clinical trial research. The intervention(s) to be tested must be in a developed and testable form, with Stage I activities already completed and demonstrated.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 5, 2029, allowing time for registration and validation.
Related grant opportunities
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
- Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)
- NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
- Research Initiatives at the Naval Postgraduate School
- Department of War Cyber Service Academy (DoW CSA)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.